SMA Newsroom

The research study on Spinal Cord Stimulation in Spinal Muscular Atrophy is still recruiting. 

Last Wednesday, 16 of October, Alice Larotonda and Laura Gumbert, on behalf of SMA Europe, presented OdySMA Real-Life Stories. 

We are delighted to invite you to read the latest features from SMA News Today and Rare Revolution Magazine, showcasing our documentary that aims to raise awareness about the importance of research in Spinal Muscular Atrophy.

We are happy to share the latest Community Statement issued by Biogen about the Phase 2/3 DEVOTE study evaluating the safety and efficacy of a higher dose regimen of nusinersen for the treatment of spinal muscular atrophy (SMA).